Sprinklr, Inc. (CXM) Spending and interest coverage
- R&D / revenue · 12 months: Value 11.21%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 9.42%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 11.21% | Research and development expense / revenue. Period ending 2026-07-31. $97.82M ÷ $872.88M × 100 ≈ 11.21% |
| Stock-based compensation / revenue · 12 months | 9.42% | Share-based compensation / revenue. Period ending 2026-07-31. $82.26M ÷ $872.88M × 100 ≈ 9.42% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 97.82M USD | Research and Development Expense |
| Revenue | 872.88M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 82.26M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 46.29M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $97.82M | $872.88M | $82.26M | $46.29M | (m) | 11.21% | 9.42% | (m) | (m) |
| 2026-04-30 | $96.55M | $871.18M | $83.16M | $52.60M | (m) | 11.08% | 9.55% | (m) | (m) |
| 2026-01-31 | $96.00M | $857.20M | $84.43M | $40.24M | (m) | 11.20% | 9.85% | (m) | (m) |
| 2025-10-31 | $93.62M | $839.15M | $78.31M | $36.53M | (m) | 11.16% | 9.33% | (m) | (m) |
| 2025-07-31 | $92.21M | $820.77M | $73.15M | $32.87M | (m) | 11.23% | 8.91% | (m) | (m) |
| 2025-04-30 | $92.27M | $805.94M | $66.94M | $16.51M | (m) | 11.45% | 8.31% | (m) | (m) |
| 2025-01-31 | $92.00M | $796.39M | $59.52M | $23.97M | (m) | 11.55% | 7.47% | (m) | (m) |
| 2024-10-31 | $92.50M | $788.06M | $57.83M | $31.97M | (m) | 11.74% | 7.34% | (m) | (m) |
| 2024-07-31 | $92.37M | $773.70M | $56.53M | $37.27M | (m) | 11.94% | 7.31% | (m) | (m) |
| 2024-04-30 | $93.07M | $754.96M | $56.30M | $42.85M | (m) | 12.33% | 7.46% | (m) | (m) |
| 2024-01-31 | $91.29M | $732.36M | $55.76M | $33.95M | (m) | 12.47% | 7.61% | (m) | (m) |
| 2023-10-31 | $88.36M | $703.48M | $57.70M | $13.67M | (m) | 12.56% | 8.20% | (m) | (m) |
| 2023-07-31 | $84.42M | $674.41M | $54.98M | $-4.13M | (m) | 12.52% | 8.15% | (m) | (m) |
| 2023-04-30 | $80.08M | $646.58M | $56.31M | $-31.29M | (m) | 12.39% | 8.71% | (m) | (m) |
| 2023-01-31 | $76.66M | $618.19M | $55.52M | $-51.22M | (m) | 12.40% | 8.98% | (m) | (m) |
| 2022-10-31 | $72.41M | $588.52M | $52.10M | $-85.20M | (m) | 12.30% | 8.85% | (m) | (m) |
| 2022-07-31 | $69.79M | $558.33M | $53.31M | $-105.37M | (m) | 12.50% | 9.55% | (m) | (m) |
| 2022-04-30 | $64.84M | $526.39M | $53.74M | $-112.10M | (m) | 12.32% | 10.21% | (m) | (m) |
| 2022-01-31 | $60.59M | $492.39M | $50.13M | $-99.47M | (m) | 12.31% | 10.18% | (m) | (m) |
| 2021-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $40.28M | $386.93M | $43.88M | $-25.58M | (m) | 10.41% | 11.34% | (m) | (m) |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | $32.48M | $324.28M | $10.17M | $-35.53M | (m) | 10.02% | 3.13% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.